Skip to content

Nasdaq · CIK 0001520697

ACHC Acadia Healthcare Company, Inc.

Insider trading from SEC Form 4. Last filing Jul 27, 2026.

Acadia Healthcare Company, Inc. (ACHC) has 45 SEC Form 4 filings on file from 16 insiders, the latest filed on Jul 27, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company

Signals

Open-market buys and sells at Acadia Healthcare Company, Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The newest 50 of 56 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jul 26, 2026Brian Farley
EVP, CLAO and Secretary
FTax withholding
Common Stock
-1,770$34.51$61k135,982Jul 27, 2026
Jun 26, 2026Brian Farley
EVP, CLAO and Secretary
FTax withholding
Common Stock
-1,370$26.24$36k137,752Jun 26, 2026
May 6, 2026E. Perot Bissell
director
AGrant or award
Common Stock
+6,331$0.00$051,986May 8, 2026
May 6, 2026Reeve B Waud
director
AGrant or award
Common Stock
+6,331$0.00$066,283May 8, 2026
May 6, 2026Patrice A Harris
director
AGrant or award
Common Stock
+6,331$0.00$017,914May 8, 2026
May 6, 2026Jason Bernhard
director
AGrant or award
Common Stock
+6,331$0.00$040,235May 8, 2026
May 6, 2026William Grieco
director
AGrant or award
Common Stock
+6,331$0.00$096,212May 8, 2026
May 6, 2026Ralph David Kelly
director
AGrant or award
Common Stock
+6,331$0.00$026,358May 8, 2026
May 6, 2026Vicky B Gregg
director
AGrant or award
Common Stock
+6,331$0.00$042,628May 8, 2026
May 6, 2026Daniel J Cancelmi
director
AGrant or award
Common Stock
+6,331$0.00$012,956May 8, 2026
May 6, 2026Michael Fucci
director
AGrant or award
Common Stock
+6,331$0.00$028,152May 8, 2026
May 6, 2026Reeve B Waud
director
AGrant or award
Common Stock
+9,576$0.00$075,859May 8, 2026
May 6, 2026Jason Bernhard
director
AGrant or award
Common Stock
+5,124$0.00$045,359May 8, 2026
May 6, 2026E. Perot Bissell
director
AGrant or award
Common Stock
+5,500$0.00$057,486May 8, 2026
May 5, 2026Brian Farley
EVP, CLAO and Secretary
FTax withholding
Common Stock
-5,063$27.69$140k139,122May 6, 2026
Apr 28, 2026Brian Farley
EVP, CLAO and Secretary
AGrant or award
Common Stock
+37,510$0.00$0144,185Apr 30, 2026
Apr 10, 2026Todd S. Young
Chief Financial Officer
AGrant or award
Common Stock
+58,799$0.00$0107,244Apr 13, 2026
Apr 10, 2026Brian Farley
EVP, GC and Secretary
AGrant or award
Common Stock
+37,510$0.00$0106,675Apr 13, 2026
Mar 12, 2026Daniel J Cancelmi
director
AGrant or award
Common Stock
+6,625$0.00$06,625Mar 18, 2026
Feb 27, 2026Brian Farley
EVP, GC and Secretary
FTax withholding
Common Stock
-1,915$22.29$43k69,165Feb 27, 2026
Jan 20, 2026Debra K Osteen
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
+1,125,000$0.00$01,125,000Jan 21, 2026
Oct 27, 2025Todd S. Young
Chief Financial Officer
AGrant or award
Common Stock
+48,445$0.00$048,445Oct 28, 2025
Sep 30, 2025Nasser Khan
Chief Operating Officer
FTax withholding
Common Stock
-973$24.54$24k55,023Oct 1, 2025
Jul 26, 2025Brian Farley
EVP, GC and Secretary
FTax withholding
Common Stock
-1,095$22.26$24k71,080Jul 29, 2025
Jul 25, 2025Heather Brianne Dixon
Chief Financial Officer
FTax withholding
Common Stock
-2,410$21.74$52k118,581Jul 29, 2025
Jun 26, 2025Brian Farley
EVP, GC and Secretary
FTax withholding
Common Stock
-847$20.94$18k72,175Jun 27, 2025
Jun 26, 2025Heather Brianne Dixon
Chief Financial Officer
FTax withholding
Common Stock
-1,508$20.94$32k120,991Jun 27, 2025
Jun 26, 2025Christopher H. Hunter
Chief Executive Officer
FTax withholding
Common Stock
-5,464$20.94$114k258,530Jun 27, 2025
May 29, 2025Ralph David Kelly
director
AGrant or award
Common Stock
+7,032$0.00$015,104May 30, 2025
May 29, 2025Michael Fucci
director
AGrant or award
Common Stock
+7,032$0.00$021,821May 30, 2025
May 29, 2025Reeve B Waud
director
AGrant or award
Common Stock
+7,032$0.00$049,315May 30, 2025
May 29, 2025William Grieco
director
AGrant or award
Common Stock
+7,032$0.00$085,486May 30, 2025
May 29, 2025Vicky B Gregg
director
AGrant or award
Common Stock
+7,032$0.00$036,297May 30, 2025
May 29, 2025Wade D Miquelon
director
AGrant or award
Common Stock
+7,032$0.00$055,520May 30, 2025
May 29, 2025E. Perot Bissell
director
AGrant or award
Common Stock
+7,032$0.00$045,655May 30, 2025
May 29, 2025Patrice A Harris
director
AGrant or award
Common Stock
+7,032$0.00$011,583May 30, 2025
May 29, 2025Jason Bernhard
director
AGrant or award
Common Stock
+7,032$0.00$029,421May 30, 2025
May 29, 2025Ralph David Kelly
director
AGrant or award
Common Stock
+4,923$0.00$020,027May 30, 2025
May 29, 2025Reeve B Waud
director
AGrant or award
Common Stock
+10,637$0.00$059,952May 30, 2025
May 29, 2025William Grieco
director
AGrant or award
Common Stock
+4,395$0.00$089,881May 30, 2025
May 29, 2025Jason Bernhard
director
AGrant or award
Common Stock
+4,483$0.00$033,904May 30, 2025
May 9, 2025Christopher H. Hunter
Chief Executive Officer
FTax withholding
Common Stock
-1,889$24.22$46k263,994May 13, 2025
May 5, 2025Christopher H. Hunter
Chief Executive Officer
AGrant or award
Common Stock
+115,818$0.00$0247,102May 7, 2025
May 5, 2025Nasser Khan
Chief Operating Officer
AGrant or award
Common Stock
+30,676$0.00$055,996May 7, 2025
May 5, 2025Brian Farley
EVP, GC and Secretary
AGrant or award
Common Stock
+38,606$0.00$073,022May 7, 2025
May 5, 2025Heather Brianne Dixon
Chief Financial Officer
AGrant or award
Common Stock
+43,823$0.00$0122,499May 7, 2025
May 5, 2025Christopher H. Hunter
Chief Executive Officer
AGrant or award
Common Stock
+18,781$0.00$0265,883May 7, 2025
Apr 11, 2025Christopher H. Hunter
Chief Executive Officer
FTax withholding
Common Stock
-1,477$27.08$40k131,284Apr 11, 2025
Mar 1, 2025Nasser Khan
Chief Operating Officer
FTax withholding
Common Stock
-226$29.98$6,77525,320Mar 3, 2025
Feb 27, 2025Christopher H. Hunter
Chief Executive Officer
AGrant or award
Common Stock
+6,672$0.00$0136,632Feb 28, 2025
50 of 56 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about ACHC

Answered from the filings on this page, as of the latest one.

Are insiders buying ACHC?

No. In the last 90 days no insider at Acadia Healthcare Company, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade ACHC on the open market?

No open-market trade has been scored at Acadia Healthcare Company, Inc.. The latest Form 4 on file was filed on Jul 27, 2026 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Acadia Healthcare Company, Inc.?

16 people have filed a Form 4 at Acadia Healthcare Company, Inc., among them Jason Bernhard (director), E. Perot Bissell (director), Daniel J Cancelmi (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ACHC insider trading: Acadia Healthcare Company, Inc. | InsiderTell